Oppenheimer Maintains Outperform on Centene, Raises Price Target to $95
Oppenheimer analyst Michael Wiederhorn maintains Centene (NYSE:CNC) with a Outperform and raises the price target from $90 to $95.
CNBC’s Final Call: Centene, Meta Platforms, And Consumer Staples
On CNBC's "Options Action: The Final Call," Carter Braxton Worth said Centene Corp (NYSE: CNC) was a defensive stock that was “acting offensively.” The stock jumped almost 5% to settle at $78.45 on Frid
Wells Fargo Maintains Overweight on Centene, Raises Price Target to $90
Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $88 to $90.
Credit Suisse Maintains Neutral on Centene, Raises Price Target to $86
Credit Suisse maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $75 to $86.
Centene Arizona Subsidiaries Awarded Contract Expansion To Continue Serving Arizonans With Serious Mental Illness
Centene Corporation (NYSE:CNC) announced today its Arizona subsidiaries Arizona Complete Health-Complete Care Plan and Care1st Health Plan Arizona were selected by the Arizona Health Care Cost Containment
Director Of Centene Sold $1.4M In Stock
Richard Gephardt, Director at Centene (NYSE:CNC), made a large insider sell on October 28, according to a new SEC filing.
4 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Analyst Ratings For Centene
Analysts have provided the following ratings for Centene (NYSE:CNC) within the last quarter:
Morgan Stanley Maintains Overweight on Centene, Raises Price Target to $86
Morgan Stanley analyst Ricky Goldwasser maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $79 to $86.